Cutaneous Melanoma Terminated Phase 1 Trials for Perflubutane (DB12821)

IndicationStatusPhase
DBCOND0040978 (Cutaneous Melanoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02968680Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous MelanomaDiagnostic